Product Name

  • Name

    Azilsartan

  • EINECS 808-058-6
  • CAS No. 147403-03-0
  • Article Data35
  • CAS DataBase
  • Density 1.42 cm3
  • Solubility
  • Melting Point 188 °C(dec.)
  • Formula C25H20N4O5
  • Boiling Point
  • Molecular Weight 456.458
  • Flash Point
  • Transport Information
  • Appearance
  • Safety
  • Risk Codes
  • Molecular Structure Molecular Structure of 147403-03-0 (Azilsartan)
  • Hazard Symbols
  • Synonyms see 1H-Benzimidazole-7-carboxylic acid,1-[[2'-(2,5-dihydro-5-oxo-1,2,4-oxadiazol- 3-yl)[1,1'-biphenyl]-4-yl]methyl]-2- ethoxy-;TAK 536;2-Ethoxy-1-[[2'-(4,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylic acid;
  • PSA 123.24000
  • LogP 4.19180

Synthetic route

ethyl ester of 2-ethoxy-1-((2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl)methyl)-1H-benzo[d]-imidazole-7-carboxylic acid
1403474-70-3

ethyl ester of 2-ethoxy-1-((2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl)methyl)-1H-benzo[d]-imidazole-7-carboxylic acid

azilsartan
147403-03-0

azilsartan

Conditions
ConditionsYield
With water; sodium hydroxide at 50℃; for 4h;98.5%
With sodium hydroxide In water at 70 - 75℃; for 1.5h; Temperature;93.4%
With pyrographite; sodium hydroxide In water at 55℃; for 2h; Temperature;91%
C25H19N4O5(1-)*Na(1+)

C25H19N4O5(1-)*Na(1+)

azilsartan
147403-03-0

azilsartan

Conditions
ConditionsYield
With citric acid In water at 5℃; pH=5; Reagent/catalyst;97.1%
methyl 2-ethoxy-1-((2′-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl)methyl)-1H-benzo[d]-imidazole-7-carboxylate
147403-52-9

methyl 2-ethoxy-1-((2′-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl)methyl)-1H-benzo[d]-imidazole-7-carboxylate

azilsartan
147403-03-0

azilsartan

Conditions
ConditionsYield
Stage #1: methyl 2-ethoxy-1-((2′-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl)methyl)-1H-benzo[d]-imidazole-7-carboxylate With water; sodium hydroxide In methanol at 20℃; for 24h;
Stage #2: With hydrogenchloride In water Product distribution / selectivity;
96.4%
With sodium hydroxide In methanol; water at 20℃; for 24h;96%
With sodium hydroxide In water at 60 - 65℃; Temperature;96.8%
C25H19N4O5(1-)*K(1+)

C25H19N4O5(1-)*K(1+)

azilsartan
147403-03-0

azilsartan

Conditions
ConditionsYield
With citric acid In water at 5℃; pH=5; Reagent/catalyst;96.7%
0.36N-NaOH

0.36N-NaOH

pyrographite
7440-44-0

pyrographite

methyl 2-ethoxy-1-((2′-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl)methyl)-1H-benzo[d]-imidazole-7-carboxylate
147403-52-9

methyl 2-ethoxy-1-((2′-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl)methyl)-1H-benzo[d]-imidazole-7-carboxylate

azilsartan
147403-03-0

azilsartan

Conditions
ConditionsYield
96%
0.40N-NaOH

0.40N-NaOH

pyrographite
7440-44-0

pyrographite

methyl 2-ethoxy-1-((2′-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl)methyl)-1H-benzo[d]-imidazole-7-carboxylate
147403-52-9

methyl 2-ethoxy-1-((2′-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl)methyl)-1H-benzo[d]-imidazole-7-carboxylate

azilsartan
147403-03-0

azilsartan

Conditions
ConditionsYield
96%
C25H19N4O5(1-)*Li(1+)

C25H19N4O5(1-)*Li(1+)

azilsartan
147403-03-0

azilsartan

Conditions
ConditionsYield
With citric acid In water at 5℃; pH=5; Reagent/catalyst;95.8%
Azilsartan medoxomil
863031-21-4

Azilsartan medoxomil

azilsartan
147403-03-0

azilsartan

Conditions
ConditionsYield
With water; sodium hydroxide at 75℃; for 1h; Temperature; Reagent/catalyst;94.84%
With Bis(p-nitrophenyl) phosphate In acetonitrile at 37℃; for 0.0833333h; pH=7.4; Kinetics; Reagent/catalyst; Enzymatic reaction;
2-ethoxy-1-[[2′-(2,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid ethyl ester di-n-butylamine

2-ethoxy-1-[[2′-(2,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid ethyl ester di-n-butylamine

azilsartan
147403-03-0

azilsartan

Conditions
ConditionsYield
With water; sodium hydroxide In ethanol at 45 - 56℃; for 2.5h;93%
C28H28N4O5

C28H28N4O5

azilsartan
147403-03-0

azilsartan

Conditions
ConditionsYield
With sodium hydroxide In tetrahydrofuran; water at 40 - 50℃; for 1h; Reagent/catalyst;92.8%
ethyl 2-ethoxy-1-((2′-(N′-hydroxycarbamimidoyl)biphenyl-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate
1397836-41-7

ethyl 2-ethoxy-1-((2′-(N′-hydroxycarbamimidoyl)biphenyl-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate

chloroformic acid ethyl ester
541-41-3

chloroformic acid ethyl ester

azilsartan
147403-03-0

azilsartan

Conditions
ConditionsYield
Stage #1: ethyl 2-ethoxy-1-((2′-(N′-hydroxycarbamimidoyl)biphenyl-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate; chloroformic acid ethyl ester With triethylamine In toluene at 30℃; for 2h;
Stage #2: With dmap; water In toluene for 3h; Reflux;
89%
2-ethoxy-1-[[2'-[N'((ethoxycarbonyl)oxy)carbamimidoyl][1,1-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid methyl ester
147404-82-8

2-ethoxy-1-[[2'-[N'((ethoxycarbonyl)oxy)carbamimidoyl][1,1-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid methyl ester

azilsartan
147403-03-0

azilsartan

Conditions
ConditionsYield
With sodium hydroxide In water at 40℃; for 2h; Reagent/catalyst; Temperature;87%
Multi-step reaction with 2 steps
1.1: xylene / 1.5 h / Reflux
2.1: sodium hydroxide; water / 1.5 h / 70 °C
2.2: pH 3
View Scheme
Multi-step reaction with 2 steps
1: xylene / 1.5 h / Reflux
2: sodium hydroxide; water / methanol / 24 h / 20 °C
View Scheme
methyl 2-ethoxy-1-((2'-(N'-(phenoxycarbonyloxy)carbamimidoyl)biphenyl-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate
1403477-44-0

methyl 2-ethoxy-1-((2'-(N'-(phenoxycarbonyloxy)carbamimidoyl)biphenyl-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate

azilsartan
147403-03-0

azilsartan

Conditions
ConditionsYield
With water; sodium hydroxide at 100℃; for 3h; Reagent/catalyst;84%
Multi-step reaction with 2 steps
1.1: potassium carbonate / 1-methyl-pyrrolidin-2-one / 1 h / 20 °C
2.1: sodium hydroxide; water / 1.5 h / 70 °C
2.2: pH 3
View Scheme
Multi-step reaction with 2 steps
1: potassium carbonate / 1-methyl-pyrrolidin-2-one / 2 h / 20 °C
2: sodium hydroxide / water; methanol / 24 h / 20 °C
View Scheme
1-[(2'-(N'-hydroxycarbamimidoyl)[1,1'-biphenyl]-4-yl)methyl]-2-ethoxy-1H-1,3-benzodiazole-7-carboxylic acid
1397836-49-5

1-[(2'-(N'-hydroxycarbamimidoyl)[1,1'-biphenyl]-4-yl)methyl]-2-ethoxy-1H-1,3-benzodiazole-7-carboxylic acid

phenyl chloroformate
1885-14-9

phenyl chloroformate

azilsartan
147403-03-0

azilsartan

Conditions
ConditionsYield
With sodium hydroxide In water at 100℃; for 3h; Reagent/catalyst; Solvent;82%
1-[(2'-(N'-hydroxycarbamimidoyl)[1,1'-biphenyl]-4-yl)methyl]-2-ethoxy-1H-1,3-benzodiazole-7-carboxylic acid
1397836-49-5

1-[(2'-(N'-hydroxycarbamimidoyl)[1,1'-biphenyl]-4-yl)methyl]-2-ethoxy-1H-1,3-benzodiazole-7-carboxylic acid

methyl chloroformate
79-22-1

methyl chloroformate

azilsartan
147403-03-0

azilsartan

Conditions
ConditionsYield
With sodium hydroxide In water at 100℃; for 3h;80%
carbonic acid dimethyl ester
616-38-6

carbonic acid dimethyl ester

methyl 2-ethoxy-1-((2′-(N′-hydroxycarbamimidoyl)-biphenyl-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate
147403-65-4

methyl 2-ethoxy-1-((2′-(N′-hydroxycarbamimidoyl)-biphenyl-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate

azilsartan
147403-03-0

azilsartan

Conditions
ConditionsYield
Stage #1: carbonic acid dimethyl ester; methyl 2-ethoxy-1-((2′-(N′-hydroxycarbamimidoyl)-biphenyl-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate With potassium tert-butylate In dimethyl sulfoxide at 100℃; for 4h;
Stage #2: With hydrogenchloride In water; dimethyl sulfoxide Product distribution / selectivity;
78.9%
1-[(2'-(N'-hydroxycarbamimidoyl)[1,1'-biphenyl]-4-yl)methyl]-2-ethoxy-1H-1,3-benzodiazole-7-carboxylic acid
1397836-49-5

1-[(2'-(N'-hydroxycarbamimidoyl)[1,1'-biphenyl]-4-yl)methyl]-2-ethoxy-1H-1,3-benzodiazole-7-carboxylic acid

isopropyl chloroformate
108-23-6

isopropyl chloroformate

azilsartan
147403-03-0

azilsartan

Conditions
ConditionsYield
With sodium hydroxide In water at 100℃; for 3h;78%
carbon dioxide
124-38-9

carbon dioxide

C24H19BrN4O3

C24H19BrN4O3

azilsartan
147403-03-0

azilsartan

Conditions
ConditionsYield
With n-butyllithium In tetrahydrofuran at -70℃; Inert atmosphere;71%
methyl 1-[(2'-cyanobiphenyl-4-yl)methyl]-2-ethoxy-benzimidazole-7-carboxylate
139481-44-0

methyl 1-[(2'-cyanobiphenyl-4-yl)methyl]-2-ethoxy-benzimidazole-7-carboxylate

azilsartan
147403-03-0

azilsartan

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 55 percent / hydroxylamine / dimethylsulfoxide / 15 h / 75 °C
2: pyridine / dimethylformamide / 0.5 h / 0 °C
3: xylene / 2 h / Heating
4: 94 percent / 0.4 N aq. NaOH / 1.5 h / 70 °C
View Scheme
Multi-step reaction with 3 steps
1.1: hydroxylamine hydrochloride; sodium hydrogencarbonate / dimethyl sulfoxide / 18 h / 25 - 90 °C
2.1: 1,8-diazabicyclo[5.4.0]undec-7-ene / tetrahydrofuran / 20 - 25 °C
3.1: sodium hydroxide; water / 0.5 h / 50 - 55 °C
3.2: 0.5 h / 20 - 25 °C / pH 2 - 3
View Scheme
Multi-step reaction with 3 steps
1: hydroxylamine hydrochloride / dimethyl sulfoxide; water / 18 h / 90 °C
2: 1,8-diazabicyclo[5.4.0]undec-7-ene / dimethyl sulfoxide / 4 h / 20 °C
3: sodium hydroxide; water / 3 h / 50 °C
View Scheme
methyl 2-ethoxy-1-((2′-(N′-hydroxycarbamimidoyl)-biphenyl-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate
147403-65-4

methyl 2-ethoxy-1-((2′-(N′-hydroxycarbamimidoyl)-biphenyl-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate

azilsartan
147403-03-0

azilsartan

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: pyridine / dimethylformamide / 0.5 h / 0 °C
2: xylene / 2 h / Heating
3: 94 percent / 0.4 N aq. NaOH / 1.5 h / 70 °C
View Scheme
Multi-step reaction with 2 steps
1.1: 1,8-diazabicyclo[5.4.0]undec-7-ene / tetrahydrofuran / 20 - 25 °C
2.1: sodium hydroxide; water / 0.5 h / 50 - 55 °C
2.2: 0.5 h / 20 - 25 °C / pH 2 - 3
View Scheme
Multi-step reaction with 3 steps
1.1: triethylamine / dichloromethane; tetrahydrofuran / 2 h / 20 °C / Cooling with water-ice
2.1: xylene / 1.5 h / Reflux
3.1: sodium hydroxide; water / 1.5 h / 70 °C
3.2: pH 3
View Scheme
C34H40N4O6

C34H40N4O6

azilsartan
147403-03-0

azilsartan

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: xylene / 2 h / Heating
2: 94 percent / 0.4 N aq. NaOH / 1.5 h / 70 °C
View Scheme
Multi-step reaction with 2 steps
1.1: xylene / 2 h / Reflux
2.1: sodium hydroxide; water / 1.5 h / 70 °C
2.2: pH 3
View Scheme
Multi-step reaction with 2 steps
1: xylene / 2 h / Reflux
2: sodium hydroxide; water / methanol / 24 h / 20 °C
View Scheme
chloroformic acid ethyl ester
541-41-3

chloroformic acid ethyl ester

methyl 2-ethoxy-1-((2′-(N′-hydroxycarbamimidoyl)-biphenyl-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate
147403-65-4

methyl 2-ethoxy-1-((2′-(N′-hydroxycarbamimidoyl)-biphenyl-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate

azilsartan
147403-03-0

azilsartan

Conditions
ConditionsYield
Stage #1: chloroformic acid ethyl ester; methyl 2-ethoxy-1-((2′-(N′-hydroxycarbamimidoyl)-biphenyl-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate With pyridine In N,N-dimethyl-formamide for 6h; Inert atmosphere; Cooling with ice-cold bath;
Stage #2: With potassium tert-butylate In dimethyl sulfoxide at 20℃; for 5h;
Stage #3: With hydrogenchloride In water; dimethyl sulfoxide
methyl 2-ethoxy-1-((2'-(N'-(methoxycarbonyloxy)carbamimidoyl)biphenyl-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate
1403477-45-1

methyl 2-ethoxy-1-((2'-(N'-(methoxycarbonyloxy)carbamimidoyl)biphenyl-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate

azilsartan
147403-03-0

azilsartan

Conditions
ConditionsYield
With sodium methylate In tetrahydrofuran at 20℃; for 4h;71.2 %Chromat.
Multi-step reaction with 2 steps
1.1: sodium methylate / 1-methyl-pyrrolidin-2-one / 4 h / 20 °C
2.1: sodium hydroxide; water / 1.5 h / 70 °C
2.2: pH 3
View Scheme
Multi-step reaction with 2 steps
1.1: potassium tert-butylate / 1-methyl-pyrrolidin-2-one / 4 h / 20 °C
2.1: pyridine / N,N-dimethyl-formamide / 6 h / Inert atmosphere; Cooling with ice-cold bath
2.2: 5 h / 20 °C
View Scheme
methyl 2-ethoxy-1-((2'-(N'-(methoxycarbonyloxy)carbamimidoyl)biphenyl-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate
1403477-45-1

methyl 2-ethoxy-1-((2'-(N'-(methoxycarbonyloxy)carbamimidoyl)biphenyl-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate

A

azilsartan
147403-03-0

azilsartan

B

methyl 2-ethoxy-1-((2′-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl)methyl)-1H-benzo[d]-imidazole-7-carboxylate
147403-52-9

methyl 2-ethoxy-1-((2′-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl)methyl)-1H-benzo[d]-imidazole-7-carboxylate

Conditions
ConditionsYield
With sodium methylate In 1-methyl-pyrrolidin-2-one at 20℃; for 4h;A 11.3 %Chromat.
B 72.7 %Chromat.
With sodium methylate In dimethyl sulfoxide at 20℃; for 4h;A 77.9 %Chromat.
B 17.1 %Chromat.
methyl 2-ethoxy-1-((2'-(N'-(methoxycarbonyloxy)carbamimidoyl)biphenyl-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate
1403477-45-1

methyl 2-ethoxy-1-((2'-(N'-(methoxycarbonyloxy)carbamimidoyl)biphenyl-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate

A

methyl 2-ethoxy-1-((2′-(N′-hydroxycarbamimidoyl)-biphenyl-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate
147403-65-4

methyl 2-ethoxy-1-((2′-(N′-hydroxycarbamimidoyl)-biphenyl-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate

B

azilsartan
147403-03-0

azilsartan

Conditions
ConditionsYield
With potassium tert-butylate In 1-methyl-pyrrolidin-2-one at 20℃; for 4h; Product distribution / selectivity;A 7.9 %Chromat.
B 74.8 %Chromat.
ethyl 2-ethoxy-1-((2'-(N'-((ethoxycarbonyl)oxy)carbamimidoyl)[biphenyl]-4-yl)methyl)-1H-benzoimidazole-7-carboxylate
1403474-75-8

ethyl 2-ethoxy-1-((2'-(N'-((ethoxycarbonyl)oxy)carbamimidoyl)[biphenyl]-4-yl)methyl)-1H-benzoimidazole-7-carboxylate

azilsartan
147403-03-0

azilsartan

Conditions
ConditionsYield
With sodium ethanolate In tetrahydrofuran at 20℃; for 4h;66 %Chromat.
With potassium tert-butylate In tetrahydrofuran at 20℃; for 4h; Product distribution / selectivity;93 %Chromat.
Multi-step reaction with 2 steps
1: dibutylamine / 2 h / 110 - 115 °C
2: sodium hydroxide; water / 1.5 h / 70 - 75 °C
View Scheme
Multi-step reaction with 2 steps
1: isopropyl alcohol / 80 °C
2: pyrographite; sodium hydroxide / water / 2 h / 55 °C
View Scheme
ethyl 2-ethoxy-1-((2'-(N'-((ethoxycarbonyl)oxy)carbamimidoyl)[biphenyl]-4-yl)methyl)-1H-benzoimidazole-7-carboxylate
1403474-75-8

ethyl 2-ethoxy-1-((2'-(N'-((ethoxycarbonyl)oxy)carbamimidoyl)[biphenyl]-4-yl)methyl)-1H-benzoimidazole-7-carboxylate

A

ethyl ester of 2-ethoxy-1-((2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl)methyl)-1H-benzo[d]-imidazole-7-carboxylic acid
1403474-70-3

ethyl ester of 2-ethoxy-1-((2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl)methyl)-1H-benzo[d]-imidazole-7-carboxylic acid

B

azilsartan
147403-03-0

azilsartan

Conditions
ConditionsYield
With sodium ethanolate In dimethyl sulfoxide at 20℃; for 4h; Product distribution / selectivity;A 39.3 %Chromat.
B 55.3 %Chromat.
ethyl 1-[(2'-cyano-[1,1']-biphenyl-4-yl)methyl]-2-ethoxy-1H-benzo[d]imidazole-7-carboxylate
139481-41-7

ethyl 1-[(2'-cyano-[1,1']-biphenyl-4-yl)methyl]-2-ethoxy-1H-benzo[d]imidazole-7-carboxylate

azilsartan
147403-03-0

azilsartan

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: hydroxylamine hydrochloride / dimethyl sulfoxide; water / 15 h / 90 °C
2: dimethyl sulfoxide; methanol / 2 h / 20 - 25 °C
3: sodium hydroxide; water / 3 h / 50 °C
View Scheme
Multi-step reaction with 3 steps
1: triethylamine; hydroxylamine hydrochloride / dimethyl sulfoxide / 12 h / 75 °C
2: 1,8-diazabicyclo[5.4.0]undec-7-ene / tetrahydrofuran / 2 h / 20 °C
3: sodium hydroxide / 75 °C
View Scheme
Multi-step reaction with 4 steps
1: triethylamine; hydroxylamine / ethanol; water / 7 h
2: triethylamine / dichloromethane / 2 h / 20 °C
3: ethanol / 15 h / Reflux
4: sodium hydroxide / ethanol / 1.6 h / 73 - 75 °C
View Scheme
ethyl 2-ethoxy-1-((2′-(N′-hydroxycarbamimidoyl)biphenyl-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate
1397836-41-7

ethyl 2-ethoxy-1-((2′-(N′-hydroxycarbamimidoyl)biphenyl-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate

azilsartan
147403-03-0

azilsartan

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: dimethyl sulfoxide; methanol / 2 h / 20 - 25 °C
2: sodium hydroxide; water / 3 h / 50 °C
View Scheme
Multi-step reaction with 3 steps
1: triethylamine / dichloromethane / 2 h / 20 °C
2: ethanol / 15 h / Reflux
3: sodium hydroxide / ethanol / 1.6 h / 73 - 75 °C
View Scheme
Multi-step reaction with 3 steps
1: triethylamine / dichloromethane / 2 h / 20 °C
2: ethanol / 15 h / Reflux
3: sodium hydroxide / ethanol / 1.6 h / 73 - 75 °C
View Scheme
azilsartan
147403-03-0

azilsartan

1-[[2'-(carbamimidoyl)[1,1'-biphenyl]-4-yl]methyl]-2-ethoxy-1H-benzimidazole-7-carboxylic acid

1-[[2'-(carbamimidoyl)[1,1'-biphenyl]-4-yl]methyl]-2-ethoxy-1H-benzimidazole-7-carboxylic acid

Conditions
ConditionsYield
With palladium on activated charcoal; ammonium formate; acetic acid In ethanol at 80℃; for 5h; Inert atmosphere;96%
4-hydroxymethyl-5-methyl-[1,3]dioxol-2-one
91526-18-0

4-hydroxymethyl-5-methyl-[1,3]dioxol-2-one

azilsartan
147403-03-0

azilsartan

Azilsartan medoxomil
863031-21-4

Azilsartan medoxomil

Conditions
ConditionsYield
Stage #1: 4-hydroxymethyl-5-methyl-[1,3]dioxol-2-one; azilsartan With dmap; potassium carbonate; p-toluenesulfonyl chloride In N,N-dimethyl acetamide at 10℃; for 3h;
Stage #2: In N,N-dimethyl acetamide pH=5;
Stage #3: In water; acetone at 35℃; for 2h;
95%
Stage #1: 4-hydroxymethyl-5-methyl-[1,3]dioxol-2-one; azilsartan With dmap; p-toluoylsulfonylchloride; potassium carbonate In ISOPROPYLAMIDE at -15 - 25℃;
Stage #2: With hydrogenchloride In ISOPROPYLAMIDE; water for 0.5h; pH=4 - 5;
81%
With dmap; potassium carbonate; p-toluenesulfonyl chloride In N,N-dimethyl acetamide at 8 - 10℃; for 3h;80.1%
3-(hydroxymethyl)-4-phenylfuroxan
135733-30-1

3-(hydroxymethyl)-4-phenylfuroxan

azilsartan
147403-03-0

azilsartan

3-(4-phenyl-1,2,5-oxadiazole-2-oxide-3-)methyl-2-ethoxy-1-{[2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazole-3-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylate

3-(4-phenyl-1,2,5-oxadiazole-2-oxide-3-)methyl-2-ethoxy-1-{[2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazole-3-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylate

Conditions
ConditionsYield
With dmap; triethylamine; p-toluenesulfonyl chloride In dichloromethane at 20℃; for 5h; Reagent/catalyst; Solvent; Temperature;94%
With dmap; potassium carbonate; p-toluenesulfonyl chloride In N,N-dimethyl-formamide at 10℃; for 3h;
N,N-dimethyl acetamide
127-19-5

N,N-dimethyl acetamide

4-hydroxymethyl-5-methyl-[1,3]dioxol-2-one
91526-18-0

4-hydroxymethyl-5-methyl-[1,3]dioxol-2-one

azilsartan
147403-03-0

azilsartan

(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester of 1-[[2'-(2,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1'-biphenyl]-4-yl]methyl]-2-ethoxy-1H-benzimidazole-7-carboxylic acid dimethylacetamide
1417575-99-5

(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester of 1-[[2'-(2,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1'-biphenyl]-4-yl]methyl]-2-ethoxy-1H-benzimidazole-7-carboxylic acid dimethylacetamide

Conditions
ConditionsYield
With dmap; potassium carbonate; p-toluenesulfonyl chloride at 30℃; for 3h; Cooling;86.4%
4-chloromethyl-5-methyl-1,3-dioxol-2-one
80841-78-7

4-chloromethyl-5-methyl-1,3-dioxol-2-one

azilsartan
147403-03-0

azilsartan

C35H28N4O11

C35H28N4O11

Conditions
ConditionsYield
With sodium carbonate; sodium iodide In N,N-dimethyl acetamide at 35℃; for 3h; Reagent/catalyst; Solvent;85.9%
4-bromomethyl-1,3-dioxa-5-methylcyclopentene-2-one
80715-22-6

4-bromomethyl-1,3-dioxa-5-methylcyclopentene-2-one

azilsartan
147403-03-0

azilsartan

C35H28N4O11

C35H28N4O11

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 60℃; for 6h;83%
(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl iodide
80841-79-8

(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl iodide

azilsartan
147403-03-0

azilsartan

C35H28N4O11

C35H28N4O11

Conditions
ConditionsYield
With sodium carbonate In tetrahydrofuran at 70 - 80℃; for 6h; Reagent/catalyst; Solvent;78.4%
azilsartan
147403-03-0

azilsartan

2-oxo-3-((2’-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-[1,1’-biphenyl]-4-yl)methyl)-2,3-dihydro-1H-benzo[d]imidazole-4-carboxylic acid

2-oxo-3-((2’-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-[1,1’-biphenyl]-4-yl)methyl)-2,3-dihydro-1H-benzo[d]imidazole-4-carboxylic acid

Conditions
ConditionsYield
With hydrogenchloride In ethanol; water at 20℃; for 3h; pH=2;60%
With hydrogen bromide In ethanol at 78 - 85℃; for 1h;
tetrahydrofuran
109-99-9

tetrahydrofuran

2-methylimidazole
693-98-1

2-methylimidazole

azilsartan
147403-03-0

azilsartan

C25H20N4O5*C4H6N2*C4H8O

C25H20N4O5*C4H6N2*C4H8O

Conditions
ConditionsYield
In water at 20℃; for 2h;45%
azilsartan
147403-03-0

azilsartan

2-oxo-4-hydroxymethyl-3-methyl-1,2,5-oxadiazol
183537-57-7

2-oxo-4-hydroxymethyl-3-methyl-1,2,5-oxadiazol

4-(3-methyl-1,2,5-oxadiazole-2-oxide-3-)methyl-2-ethoxy-1-{[2’-(5-oxo-4,5-dihydro-1,2,4-oxadiazole-3-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylate

4-(3-methyl-1,2,5-oxadiazole-2-oxide-3-)methyl-2-ethoxy-1-{[2’-(5-oxo-4,5-dihydro-1,2,4-oxadiazole-3-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylate

Conditions
ConditionsYield
With dmap; potassium carbonate; p-toluenesulfonyl chloride In N,N-dimethyl-formamide at 20℃; for 3h;44.4%
With dmap; potassium carbonate; p-toluenesulfonyl chloride In N,N-dimethyl-formamide at 20℃; for 3h;44.4%
2-methylimidazole
693-98-1

2-methylimidazole

acetone
67-64-1

acetone

azilsartan
147403-03-0

azilsartan

C25H20N4O5*C4H6N2*C3H6O

C25H20N4O5*C4H6N2*C3H6O

Conditions
ConditionsYield
In water at 20℃; for 2h;44%

Azilsartan Specification

The IUPAC name of Azilsartan is 2-ethoxy-3-[[4-[2-(5-oxo-2H-1,2,4-oxadiazol-3-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylic acid. With the CAS registry number 147403-03-0, it is also named as 2-Ethoxy-1-[[2'-(4,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylic acid. The product's classification code is treatment of hypertension. Moreover, its molecular formula is C25H20N4O5 and its molecular weight is 456.45. 

The other characteristics of Azilsartan can be summarized as: (1)XLogP3-AA: 4.4; (2)H-Bond Donor: 2; (3)H-Bond Acceptor: 7; (4)Rotatable Bond Count: 7; (5)Tautomer Count: 3; (6)Exact Mass: 456.14337; (7)MonoIsotopic Mass: 456.14337; (8)Topological Polar Surface Area: 115; (9)Heavy Atom Count: 34; (10)Complexity: 783; (11)Density: 1.42 cm3.

People can use the following data to convert to the molecule structure.
(1)Canonical SMILES: CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NC(=O)ON5)C(=O)O
(2)InChI: InChI=1S/C25H20N4O5/c1-2-33-24-26-20-9-5-8-19(23(30)31)21(20)29(24)14-15-10-12-16(13-11-15)17-6-3-4-7-18(17)22-27-25(32)34-28-22/h3-13H,2,14H2,1H3,(H,30,31)(H,27,28,32)
(3)InChIKey: KGSXMPPBFPAXLY-UHFFFAOYSA-N

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View